ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
NewAmsterdam Pharma Company NV

NewAmsterdam Pharma Company NV (NAMS)

19.59
-0.28
(-1.41%)
At close: July 15 4:00PM
19.59
0.00
( 0.00% )
After Hours: 4:30PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
19.59
Bid
18.89
Ask
21.53
Volume
95,451
19.41 Day's Range 20.47
5.6326 52 Week Range 26.35
Market Cap
Previous Close
19.87
Open
20.12
Last Trade Time
16:13:36
Financial Volume
$ 1,887,758
VWAP
19.7772
Average Volume (3m)
165,649
Shares Outstanding
89,976,538
Dividend Yield
-
PE Ratio
-9.94
Earnings Per Share (EPS)
-1.97
Revenue
14.09M
Net Profit
-176.94M

About NewAmsterdam Pharma Company NV

NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibit... NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Naarden, North Holland, Nld
Founded
1970
NewAmsterdam Pharma Company NV is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker NAMS. The last closing price for NewAmsterdam Pharma Comp... was $19.87. Over the last year, NewAmsterdam Pharma Comp... shares have traded in a share price range of $ 5.6326 to $ 26.35.

NewAmsterdam Pharma Comp... currently has 89,976,538 shares outstanding. The market capitalization of NewAmsterdam Pharma Comp... is $1.79 billion. NewAmsterdam Pharma Comp... has a price to earnings ratio (PE ratio) of -9.94.

NAMS Latest News

NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors

NAARDEN, The Netherlands and MIAMI, July 08, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, The Netherlands and MIAMI, July 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...

NewAmsterdam Pharma Announces Issuance of Composition of Matter Patent for Obicetrapib by the United States Patent and Trademark Office

-- New patent extends patent term for obicetrapib until July 2043 -- NAARDEN, the Netherlands and MIAMI, June 11, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, June 07, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in June

NAARDEN, the Netherlands and MIAMI, May 29, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...

NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib’s Impact on Key Risk Factors for Cardiovascular Disease at Upcoming Medical Meetings

-- Presentations include new data from OCEAN, ROSE, and ROSE2 Phase 2 clinical trials, demonstrating obicetrapib’s impact on key lipid and lipoprotein biomarkers -- -- On track to report topline...

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

-- Enrolled over 9,500 patients in Phase 3 PREVAIL global CVOT-- -- On-track to report topline data from Phase 3 BROOKLYN trial in HeFH in 3Q 2024 and Phase 3 BROADWAY trial in ASCVD in 4Q 2024...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.44-2.1967049425920.0321.435819.4138089720.15384037CS
40.542.8346456692919.0521.435816.620122956619.55537907CS
12-0.42-2.0989505247420.0123.0116.620116564919.92093822CS
261.116.0064935064918.4826.3516.408920535320.62463708CS
527.7465.316455696211.8526.355.632616526216.80516001CS
1568.5978.09090909091132.885.632612200816.03513164CS
2608.5978.09090909091132.885.632612200816.03513164CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WNWMeiwu Technology Company Ltd
$ 1.23
(38.20%)
4.27M
SISIShineco Inc
$ 1.27
(29.59%)
2.18M
SVRESaverOne 2014 Ltd
$ 0.5401
(21.62%)
3.06M
ZENVZenvia Inc
$ 1.80
(12.50%)
3.68k
ETONEton Pharmaceuticals Inc
$ 3.69
(10.48%)
227.29k
IVPInspire Veterinary Partners Inc
$ 9.61
(-14.80%)
178.96k
CYNCYNGN Inc
$ 7.88
(-14.16%)
153.02k
DJTTrump Media and Technology Group Corporation
$ 36.2117
(-10.76%)
3.52M
CAUDCollective Audience Inc
$ 0.48
(-10.35%)
45.11k
AMIXAutonomix Medical Inc
$ 1.24
(-10.14%)
999.84k
FFIEFaraday Future Intelligent Electric Inc
$ 0.5452
(5.82%)
10.29M
AAPLApple Inc
$ 234.95
(0.23%)
4.35M
WNWMeiwu Technology Company Ltd
$ 1.23
(38.20%)
4.27M
TSLATesla Inc
$ 252.79
(0.06%)
4.26M
MAXNMaxeon Solar Technologies Ltd
$ 0.2229
(-1.81%)
3.76M

Your Recent History

Delayed Upgrade Clock